WalterH.GajewskiMD
Obstetrics & Gynecology • Wilmington, NCGynecologic Oncology
Obstetrician-gynecologist in Wilmington, North Carolina and is affiliated with New Hanover Regional Medical Center
Are you Dr. Gajewski?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 82 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2131 S 17th St
Wilmington, NC 28401Phone+1 910-667-3000Fax+1 910-667-6758
Summary
- Dr. Walter Gajewski, MD is an obstetrician/gynecologist in Wilmington, North Carolina. He is currently licensed to practice medicine in North Carolina, Rhode Island, and Massachusetts. He is affiliated with Novant Health New Hanover Regional Medical Center and is an Obstetrician-gynecologist in Wilmington at North Carolina and is affiliated with New Hanover Regional Medical Center.
Education & Training
Massachusetts General HospitalFellowship, Gynecologic Oncology, 1985 - 1987
University of ConnecticutResidency, Obstetrics and Gynecology, 1982 - 1985
Medical University of South CarolinaClass of 1982
Certifications & Licensure
NC State Medical License 2004 - 2024
RI State Medical License 1993 - 2006
CT State Medical License 1984 - 2004
MA State Medical License 1986 - 2004- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer Start of enrollment: 2005 Mar 21
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
- Join now to see all
Publications & Presentations
PubMed
- 574 citationsA novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic massRichard G. Moore, D. Scott McMeekin, A.K. Brown, Paul DiSilvestro, M. Craig Miller
Gynecologic Oncology. 2009-01-01 - 21 citationsSecretion of Activin A in Recurrent Epithelial Ovarian CarcinomaGeralyn Lambert-Messerlian, S.E. DePasquale, W.M. Maybruck, Margaret M. Steinhoff, Walter Gajewski
Gynecologic Oncology. 1999-07-01 - 187 citationsEvaluation of the Diagnostic Accuracy of the Risk of Ovarian Malignancy Algorithm in Women With a Pelvic MassRichard G. Moore, M. Craig Miller, Paul DiSilvestro, Lisa M. Landrum, Walter Gajewski
Obstetrics and Gynecology. 2011-08-01
Professional Memberships
- Fellow
- Member
